Foster & Motley Inc. Has $10.77 Million Stock Holdings in Aflac Incorporated (NYSE:AFL)

Foster & Motley Inc. cut its holdings in Aflac Incorporated (NYSE:AFL) by 3.2% in the 1st quarter, Holdings Channel.com reports. The firm owned 96,900 shares of the financial services provider’s stock after selling 3,221 shares during the quarter. Foster & Motley Inc.’s holdings in Aflac were worth $10,774,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Natixis Advisors LLC boosted its position in Aflac by 4.1% during the 1st quarter. Natixis Advisors LLC now owns 271,607 shares of the financial services provider’s stock worth $30,200,000 after acquiring an additional 10,765 shares during the last quarter. NorthRock Partners LLC boosted its position in Aflac by 1.5% during the 1st quarter. NorthRock Partners LLC now owns 6,519 shares of the financial services provider’s stock worth $725,000 after acquiring an additional 95 shares during the last quarter. Banque Cantonale Vaudoise acquired a new position in Aflac during the 1st quarter worth approximately $1,087,000. Meeder Asset Management Inc. boosted its position in Aflac by 90.8% during the 1st quarter. Meeder Asset Management Inc. now owns 330 shares of the financial services provider’s stock worth $37,000 after acquiring an additional 157 shares during the last quarter. Finally, Meeder Advisory Services Inc. boosted its position in Aflac by 1.6% during the 1st quarter. Meeder Advisory Services Inc. now owns 17,064 shares of the financial services provider’s stock worth $1,897,000 after acquiring an additional 271 shares during the last quarter. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have weighed in on AFL. Wall Street Zen downgraded Aflac from a “hold” rating to a “sell” rating in a research report on Monday, May 5th. JPMorgan Chase & Co. upped their price objective on Aflac from $96.00 to $100.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 8th. Morgan Stanley upped their price objective on Aflac from $100.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Monday, May 19th. Barclays set a $98.00 price objective on Aflac and gave the stock an “underweight” rating in a research note on Monday, July 7th. Finally, Piper Sandler upped their price objective on Aflac from $118.00 to $124.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 2nd. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Aflac presently has an average rating of “Hold” and a consensus target price of $108.15.

Insiders Place Their Bets

In other news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction on Thursday, May 8th. The stock was sold at an average price of $106.79, for a total transaction of $106,790.00. Following the sale, the director directly owned 26,096 shares of the company’s stock, valued at approximately $2,786,791.84. This represents a 3.69% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Arthur Reginald Collins sold 2,750 shares of the stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $105.70, for a total value of $290,675.00. Following the sale, the director directly owned 6,728 shares in the company, valued at approximately $711,149.60. This trade represents a 29.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 40,750 shares of company stock worth $4,304,295 in the last 90 days. Company insiders own 0.80% of the company’s stock.

Aflac Stock Down 0.1%

AFL stock opened at $100.81 on Wednesday. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.09 and a quick ratio of 0.09. The stock has a market capitalization of $54.50 billion, a price-to-earnings ratio of 15.75, a PEG ratio of 3.12 and a beta of 0.81. The business’s fifty day moving average price is $102.83 and its two-hundred day moving average price is $105.16. Aflac Incorporated has a fifty-two week low of $94.87 and a fifty-two week high of $115.50.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing the consensus estimate of $1.67 by ($0.01). The firm had revenue of $3.40 billion for the quarter, compared to the consensus estimate of $4.53 billion. Aflac had a return on equity of 15.55% and a net margin of 21.27%. The firm’s quarterly revenue was down 37.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.66 EPS. On average, equities analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.